Literature DB >> 6122101

Precursor lesions of oesophageal cancer in high-risk populations in Iran and China.

N Muñoz, M Crespi, A Grassi, W G Qing, S Qiong, L Z Cai.   

Abstract

To determine the prevalence of precursor lesions of oesophageal cancer in Linxian, People's Republic of China, which has an extremely high incidence of oesophageal cancer, 527 subjects were interviewed by a questionnaire about exposure to suspected risk factors. They also underwent oesophagoscopy, cytology, and biopsy. 84% had a chronic oesophagitis which had similar endoscopic and histological characteristics to that reported in Iran. The oesophagitis was accompanied by atrophy of the epithelium in 10% of these subjects and by dysplasia in 8%. Re-examination of 20 selected subjects 1 year later showed progression of the oesophagitis to atrophy and dysplasia in 4 individuals and to cancer in 4 others. The surveys in Iran and China suggest that the natural history of oesophageal cancer starts with an oesophagitis which, in a few individuals, progresses to atrophy and dysplasia of the epithelium and finally to cancer. Thermal injury resulting from the drinking of very hot beverages, physical injury caused by ingesting very coarse food, and deficiencies of riboflavine, vitamin A, and zinc are proposed as risk factors for these precursor lesions.

Entities:  

Mesh:

Year:  1982        PMID: 6122101     DOI: 10.1016/s0140-6736(82)92151-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study.

Authors:  Seamus J Murphy; Lesley A Anderson; Brian T Johnston; Deirdre A Fitzpatrick; Peter Rg Watson; Pauline Monaghan; Liam J Murray
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China.

Authors:  Li-Dong Wang; Qi Zhou; Jun-Ping Wei; Wan-Cai Yang; Xin Zhao; Li-Xia Wang; Jian-Xiang Zou; Shan-Shan Gao; Yong-Xin Li; CS Yang
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

3.  Endoscopy in screening for digestive cancer.

Authors:  René Lambert
Journal:  World J Gastrointest Endosc       Date:  2012-12-16

4.  Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma.

Authors:  Philip R Taylor; Christian C Abnet; Sanford M Dawsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

5.  Esophageal cancer in Kashmir--an assessment.

Authors:  M Siddiqi; R Preussmann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 6.  Epidemiology of gastro-esophageal reflux disease.

Authors:  P J Howard; R C Heading
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

7.  Decreased plasma riboflavin is associated with poor prognosis, invasion, and metastasis in esophageal squamous cell carcinoma.

Authors:  Feng Pan; Hong-Jun Luo; Zhi-Yong Wu; Su-Zuan Chen; Xuan Wang; Shuai-Xia Yu; Jia-Min Wang; Shu-Yuan Lin; Ze-Ying Cai; Yu-Lin Gao; Pei-Tong Zhuang; Li-Yan Xu; En-Min Li
Journal:  Eur J Clin Nutr       Date:  2020-02-14       Impact factor: 4.016

8.  Squamous cell carcinoma in a large epiphrenic esophageal diverticulum.

Authors:  Jung-Jyh Hung; Chih-Cheng Hsieh; Shih-Chieh Lin; Liang-Shun Wang
Journal:  Dig Dis Sci       Date:  2009-01-30       Impact factor: 3.199

9.  Operable esophageal carcinoma: current results from Hong Kong.

Authors:  M Fok; S Y Law; J Wong
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

10.  A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis.

Authors:  Li-Dong Wang; Xiuli Bi; Xin Song; Nicole M Pohl; Yulan Cheng; Yixing Zhou; Stephen Shears; Emmanuel Ansong; Mengtao Xing; Shaomeng Wang; Xiao-Chun Xu; Peng Huang; Liyan Xu; Liang Wang; Zongmin Fan; Xueke Zhao; Huali Dong; Stephen J Meltzer; Ivan Ding; Wancai Yang
Journal:  Mol Carcinog       Date:  2013-02-06       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.